Four things to know:
- Biofourmis also announced that Omar Ishrak, PhD, former Medtronic CEO and chair at Intel, will become chair of the company’s board of directors, according to a news release.
- The funding round was led by General Atlantic, with participation from CVS Health and existing investors.
- Biofourmis will use the funds to partner with more digital health companies and scale up its offerings, including the expansion of virtual specialty care services the company launched in February. The company will also fund clinical trials developing digital therapies to improve the drugs’ efficacy, the release said.
- Biofourmis’ remote patient monitoring platform allows hospitals to establish “hospital-at-home” programs. The company worked with Boston-based Brigham and Women’s Hospital to create the Biovitals Hospital@Home program, which was unveiled in 2020. In 2022, Quincy, Ill.-based Blessing Health System and Orange, Calif.-based UCI Health partnered with the company for hospital-at-home programs.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
